Sobre este curso
Data de início
2020 - 2021
O melhor curso na melhor universidade para você
Our PGDip programme will develop your knowledge and understanding of cancer diagnosis and therapeutics. The course will focus on up-to-date diagnostic techniques and emerging tumour markers and their potential applications in specific diagnostics for various types of cancers. In addition, you will be exploring drug delivery systems and learning to make drug carriers for targeting cancers using nanotechnology. You will also be trained to perform a range of molecular, cellular and proteomics laboratory techniques used for detecting tumour markers and monitoring therapeutic effects. Why study PGDip Cancer Biomarkers and Therapeutics at Middlesex University? This programme will provide not only the necessary framework and general concepts in the cancer research field, but also an updated advanced knowledge of cancer diagnosis and treatment. In addition, you will be led by experts who are in the front line of drug development and drug delivery and acquire useful novel laboratory skills using nanotechnology and Multiplex Immunoassay-NALIA system, which will equip you with the necessary/essential skills for pursuing a range of career options. You could also proceed to further scientific training or you would be well-equipped to carry out research. A final dissertation project will be supervised by experts focusing on a variety of cancer research areas. You will be working in laboratories equipped with up-to-date instrumentation including matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI- Tof MS), liquid chromatography (LC)- MS, gas chromatography (GC)- MS, conventional and quantitative PCR, flow cytometry, Confocal microscopy, Licor Imaging system and fully equipped histopathology laboratory and tissue culture facilities.
Quer saber se pode entrar nesta Universidade?
ENTRE EM CONTATO